| Primary |
| Hypertension |
27.0% |
| Product Used For Unknown Indication |
24.3% |
| Drug Use For Unknown Indication |
21.7% |
| Type 2 Diabetes Mellitus |
4.4% |
| Epilepsy |
2.2% |
| Neuralgia |
2.2% |
| Arthralgia |
1.8% |
| Asthma |
1.8% |
| Colon Cancer |
1.8% |
| Dyslipidaemia |
1.8% |
| Osteoporosis |
1.8% |
| Atrial Fibrillation |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Hypothyroidism |
1.3% |
| Anxiety |
0.9% |
| Cerebrovascular Accident |
0.9% |
| Depression |
0.9% |
| Gout |
0.9% |
| Pain |
0.9% |
| Parkinson's Disease |
0.9% |
|
| Orthostatic Hypotension |
15.6% |
| Renal Failure Acute |
9.4% |
| Somnolence |
9.4% |
| Uterine Disorder |
9.4% |
| Drug Interaction |
6.3% |
| Hypotonia |
6.3% |
| Asthma |
3.1% |
| Cardiac Failure |
3.1% |
| Fall |
3.1% |
| Hyperuricaemia |
3.1% |
| Hypokalaemia |
3.1% |
| Hyponatraemia |
3.1% |
| Hypotension |
3.1% |
| Lactic Acidosis |
3.1% |
| Laryngeal Oedema |
3.1% |
| Lichen Planus |
3.1% |
| Lung Disorder |
3.1% |
| Malaise |
3.1% |
| Mania |
3.1% |
| Palpitations |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
23.4% |
| Drug Use For Unknown Indication |
19.6% |
| Hypertension |
15.8% |
| Ill-defined Disorder |
8.9% |
| Epilepsy |
3.8% |
| Psoriasis |
3.8% |
| Asthma |
3.2% |
| Neuralgia |
3.2% |
| Arthralgia |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Acute Coronary Syndrome |
1.9% |
| Cerebrovascular Accident |
1.9% |
| Depression |
1.9% |
| Atrial Fibrillation |
1.3% |
| Atrial Tachycardia |
1.3% |
| Dyslipidaemia |
1.3% |
| Gastric Ulcer |
1.3% |
| Parkinson's Disease |
1.3% |
| Bipolar I Disorder |
0.6% |
| Cough |
0.6% |
|
| Vomiting |
16.2% |
| Pulmonary Fibrosis |
10.8% |
| Hypokalaemia |
8.1% |
| Haemolytic Anaemia |
5.4% |
| Hypoglycaemia |
5.4% |
| Hyponatraemia |
5.4% |
| Renal Failure Acute |
5.4% |
| Respiratory Arrest |
5.4% |
| Rhabdomyolysis |
5.4% |
| Transaminases Increased |
5.4% |
| Angioedema |
2.7% |
| Asthma |
2.7% |
| Erythema Multiforme |
2.7% |
| Lichen Planus |
2.7% |
| Lung Disorder |
2.7% |
| Mania |
2.7% |
| Orthostatic Hypotension |
2.7% |
| Respiratory Failure |
2.7% |
| Somnolence |
2.7% |
| Tachycardia |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.2% |
| Multiple Myeloma |
13.3% |
| Hypertension |
13.0% |
| Product Used For Unknown Indication |
5.8% |
| Bronchitis |
5.6% |
| Thrombosis Prophylaxis |
4.4% |
| Constipation |
4.0% |
| Hepatitis C |
3.7% |
| Neutropenia |
3.5% |
| Ventricular Extrasystoles |
3.5% |
| Gout |
2.3% |
| Pulmonary Embolism |
1.9% |
| Asthma |
1.6% |
| Diabetes Mellitus |
1.6% |
| Osteoporosis |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Gastrooesophageal Reflux Prophylaxis |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Nausea |
1.4% |
| Prophylaxis |
1.4% |
|
| Cataract |
17.1% |
| Hepatitis Toxic |
7.1% |
| Rectal Haemorrhage |
7.1% |
| Vomiting |
7.1% |
| Off Label Use |
5.7% |
| Renal Failure |
5.7% |
| Thrombocytopenia |
5.7% |
| Cataract Operation |
4.3% |
| Drug Interaction |
4.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.3% |
| Toxic Skin Eruption |
4.3% |
| Urine Output Decreased |
4.3% |
| Asthmatic Crisis |
2.9% |
| Bone Marrow Failure |
2.9% |
| Hepatitis |
2.9% |
| Malaise |
2.9% |
| Neutropenia |
2.9% |
| Orthostatic Hypotension |
2.9% |
| Overdose |
2.9% |
| Pneumonitis |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
69.2% |
| Colon Cancer |
15.4% |
| Osteoporosis |
7.7% |
| Type 2 Diabetes Mellitus |
7.7% |
|
| Renal Failure |
40.0% |
| Drug Interaction |
20.0% |
| Hypoglycaemia |
20.0% |
| Vertigo |
20.0% |
|
